Median overall survival (OS) increased from 19.3 months with upfront immune checkpoint inhibition (ICI) to 41.3 months when a ...

FDA confirmed in a recent FDA Type B meeting under RMAT designation that the PROACT 1 Phase 3 study could be sufficient to support a full U.S. regulatory approval of rilparencel; ...

Infinitopes, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective immune responses, today ...

Participants were broken into two cohorts. The first cohort received one of three doses of PCRX-201. The second cohort received concurrent pretreatment with an intraarticular corticosteroid ...

MOUNTAIN VIEW, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced ...

Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced the upcoming presentation of preclinical data for ...

Students are strongly encouraged to bring copies of their resumes/CVs. The graduate school fair hosted by FURC is an excellent way to network with many universities across the country. Over 30 ...

Q3 2024 Earnings Call Transcript November 7, 2024 4:30 AM ETCompany ParticipantsBruce Mackle - LifeSci Advisors, ...

Operator instructions] I would now like to turn the conference over to Aron Feingold, vice president of investor relations ...

Communication is key to a well-functioning school environment, and posters play a vital role in spreading information ...

There are well over a hundred fonts to choose from when using Microsoft Word. While it's fun to experiment with them, it ...

Posters will be presented at the 2024 Annual Meeting of the ... By employing a multi-specific Switch-DARPin, Molecular Partners aims to bring additional dimensions of safety and potency to the ...